11.06.26 -- Is Your Supply Chain Ready For The End Of Class VI?

Cryopreservation should be integrated across the entire supply chain to ensure traceability, reduce risk at handoffs, and support consistent, scalable therapy development and delivery.

Drug manufacturers seek packaging that maintains integrity during processing and freezing, scales up to larger volumes easily, and remains robust throughout the temperature-controlled supply chain.

Through dedicated staffing, operational oversight, and close collaboration with site teams, discover how a struggling cardiology study was transformed into a revitalized recruitment effort.

Learn how early regulatory alignment can help your neurology program move forward with greater clarity, confidence, and readiness by anticipating hurdles before submitting your application.

What does the future of cell & gene therapy in neuroscience look like? Industry experts dig into the real patient experience, emerging challenges, and clinical development pathways.

Dozens of assays, a shifting sample analysis plan, and a network of specialty labs: see how coordinated oversight kept an allogeneic CAR-T trial on track.

Phase 2 neuro endpoints can miss subtle changes. Understand when composites help or hinder, and how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.